Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/eye2013236.pdf
Reference50 articles.
1. Seong HK, Bae JH, Kim ES, Han JR, Nam WH, Kim HK . Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect. Ophthalmologica 2009; 223 (5): 343–347.
2. Torres-Soriano ME, Garcia-Aguirre G, Kon-Jara V, Ustariz-Gonzales O, Abraham-Marin M, Ober MD et al. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports). Graefes Arch Clin Exp Ophthalmol 2008; 246 (9): 1235–1239.
3. Li XJ, Zhang JS . Intravitreal bevacizumab injection for chronic central serous chorioretinopathy. Chin Med J (Engl) 2010; 123 (15): 2145–2147.
4. Yannuzzi LA . Type-A behavior and central serous chorioretinopathy. Retina 1987; 7 (2): 111–131.
5. Lafaut BA, Salati C, Priem H, De Laey JJ . Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp Ophthalmol 1998; 236 (7): 513–521.
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting the Tie-2 Receptor with Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding;American Journal of Ophthalmology;2024-09
2. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-07
3. Comparison between Focal Laser Photocoagulation and Intravitreal Bevacizumab Injection for Treating Chronic Central Serous Chorioretinopathy;Journal of the Korean Ophthalmological Society;2024-04-15
4. Acute Central Serous Chorioretinopathy Outbreak during the COVID-19 Pandemic: A Pilot Study;Medicina;2024-01-09
5. Selective retina therapy with real-time feedback-controlled technology in central serous chorioretinopathy: a 24-month follow-up real-world prospective study;BMJ Open Ophthalmology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3